Abstract
This retrospective study aimed to assess the role of salvage surgery for local recurrence in hypopharyngeal cancer (HPC) patients who had received radiotherapy (RT) or concomitant chemoradiotherapy (CRT) as an initial treatment. The local recurrence rate, salvage rate after local recurrence and overall survival rate were investigated in 104 HPC patients who received treatment between 1991 and 2005. Local recurrence in the primary site was observed in 41 patients (rate, 39.4%) of whom only 12 could undergo further salvage surgery. Disease control was achieved in seven of these patients (successful salvage rate, 17.1%). The 5-year overall survival rate was 40.6% in the RT/CRT patient group and successful salvage rates for T1, T2, T3 and T4 primary disease were 33.3% (1/3), 20.0% (4/20), 16.7% (2/12) and 0% (0/6), respectively. Severe postoperative complications such as pharyngo-cutaneous fistula were seen in six patients (50.0%). Prognosis of patients with locally recurring HPC after RT/CRT is poor at any primary T-stage and the incidence of postoperative complication is relatively high. This should be taken into consideration when the initial treatment plan is decided and the choice of salvage surgery for such recurrent cases should be carefully determined.
Similar content being viewed by others
References
Pignon JP, le Maître A, Maillard E, Bourhis J, MACH-NC Collaborative Group. (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients. Radiather Oncol 92(1):4–14
Bernier J, Schneider D (2007) Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck? Eur J Cancer 43:35–45
Bernier J (2008) A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update. Curr Opin Oncol 20:249–255
Robbins KT, Vicario D, Seagren S, Weisman R, Pellitteri R, Kerber C, Orloff L, Los G, Howell SB (1994) A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 168:419–422
Soo K-C, Tan E-H, Wee J, Lim D, Tai B-C, Khoo M-L, Goh C, Leong S-S, Tan T, Fong K-W, Lu P, See A, Machin D (2005) Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer 93:279–286
Bahadur S, Thakar A, Mohanti BK, Lal P (2002) Results of radiotherapy with, or without, salvage surgery versus combined surgery and radiotherapy in advanced carcinoma of the hypopharynx. J Laryngol Otol 116:29–32
Richey LM, Shores CG, George J, Lee S, Couch MJ, Sutton DK, Weissler MC (2007) The effectiveness of salvage surgery after the failure of primary concomitant chemoradiation in head and neck cancer. Otolaryngol Head Neck Surg 136:98–103
Lee SC, Shores CG, Weissler MC (2008) Salvage surgery after failed primary concomitant chemoradiation. Curr Opin Otolaryngol Head Neck Surg 16:135–140
Leon X, Quer M, Orus C, Lopez M, Gras JR, Vega M (2001) Results of salvage surgery for local or regional recurrence after larynx preservation with induction chemotherapy and radiotherapy. Head Neck 23:733–738
Stoeckli SJ, Pawlik AB, Lipp M, Huber A, Schmid S (2000) Salvage surgery after failure of nonsurgical therapy for carcinoma of the larynx and hypopharynx. Arch Otolaryngol Head Neck Surg 126:1473–1477
Proctor E, Robbins KT, Vieira F, Hanchett C, Sommes G (2004) Postoperative complications after chemoradiation for advanced head and neck cancer. Head Neck 26:272–277
Clark JR, de Almeida J, Gilbert R, Irish J, Brown D, Neligan P, Gullane PJ (2006) Primary and salvage (hypo) pharyngectomy: analysis and outcome. Head Neck 28:671–677
Wakisaka N, Murono S, Kondo S, Furykawa M, Yoshizaki T (2008) Post-operative pharyngocutaneous fistula after laryngectomy. Auris Nasus Larynx 35:203–208
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Taki, S., Homma, A., Oridate, N. et al. Salvage surgery for local recurrence after chemoradiotherapy or radiotherapy in hypopharyngeal cancer patients. Eur Arch Otorhinolaryngol 267, 1765–1769 (2010). https://doi.org/10.1007/s00405-010-1274-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-010-1274-3